Accelerate Diagnostics Return on Tangible Equity 2010-2024 | AXDXQ
Current and historical return on tangible equity values for Accelerate Diagnostics (AXDXQ) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Accelerate Diagnostics Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $-0.05B | $-0.06B | 123.64% |
| 2024-09-30 | $-0.05B | $-0.05B | 167.44% |
| 2024-06-30 | $-0.04B | $-0.04B | 131.03% |
| 2024-03-31 | $-0.06B | $-0.03B | 196.67% |
| 2023-12-31 | $-0.06B | $-0.02B | 186.47% |
| 2023-09-30 | $-0.06B | $-0.04B | 189.63% |
| 2023-06-30 | $-0.08B | $-0.04B | 294.55% |
| 2023-03-31 | $-0.07B | $-0.04B | 201.50% |
| 2022-12-31 | $-0.06B | $-0.02B | 168.00% |
| 2022-09-30 | $-0.07B | $-0.01B | 174.23% |
| 2022-06-30 | $-0.06B | $-0.06B | 132.64% |
| 2022-03-31 | $-0.07B | $-0.06B | 133.33% |
| 2021-12-31 | $-0.08B | $-0.04B | 147.87% |
| 2021-09-30 | $-0.07B | $-0.04B | 123.85% |
| 2021-06-30 | $-0.08B | $-0.07B | 134.94% |
| 2021-03-31 | $-0.08B | $-0.07B | 150.00% |
| 2020-12-31 | $-0.08B | $-0.06B | 180.35% |
| 2020-09-30 | $-0.08B | $-0.05B | 273.50% |
| 2020-06-30 | $-0.08B | $-0.04B | 568.42% |
| 2020-03-31 | $-0.08B | $-0.02B | -5533.33% |
| 2019-12-31 | $-0.08B | $-0.01B | -466.67% |
| 2019-09-30 | $-0.09B | $0.01B | -250.00% |
| 2019-06-30 | $-0.09B | $0.03B | -171.43% |
| 2019-03-31 | $-0.09B | $0.04B | -130.88% |
| 2018-12-31 | $-0.09B | $0.06B | -105.07% |
| 2018-09-30 | $-0.08B | $0.08B | -82.62% |
| 2018-06-30 | $-0.08B | $0.10B | -68.44% |
| 2018-03-31 | $-0.07B | $0.11B | -56.34% |
| 2017-12-31 | $-0.06B | $0.12B | -54.78% |
| 2017-09-30 | $-0.06B | $0.13B | -60.14% |
| 2017-06-30 | $-0.06B | $0.14B | -66.32% |
| 2017-03-31 | $-0.07B | $0.07B | -75.80% |
| 2016-12-31 | $-0.07B | $0.08B | -67.01% |
| 2016-09-30 | $-0.06B | $0.09B | -56.12% |
| 2016-06-30 | $-0.06B | $0.11B | -57.29% |
| 2016-03-31 | $-0.05B | $0.12B | -59.65% |
| 2015-12-31 | $-0.05B | $0.13B | -64.06% |
| 2015-09-30 | $-0.04B | $0.04B | -76.64% |
| 2015-06-30 | $-0.04B | $0.05B | -63.41% |
| 2015-03-31 | $-0.04B | $0.06B | -50.72% |
| 2014-12-31 | $-0.03B | $0.07B | -48.44% |
| 2014-09-30 | $-0.03B | $0.07B | -46.75% |
| 2014-06-30 | $-0.02B | $0.08B | -43.14% |
| 2014-03-31 | $-0.02B | $0.04B | -47.37% |
| 2013-12-31 | $-0.02B | $0.04B | -44.76% |
| 2013-06-30 | $-0.01B | $0.03B | -43.90% |
| 2013-03-31 | $-0.01B | $0.03B | -65.45% |
| 2012-10-31 | $-0.01B | $0.01B | -103.70% |
| 2012-09-30 | $-0.01B | -133.33% | |
| 2012-06-30 | $0.00B | -133.33% | |
| 2012-04-30 | $0.00B | $0.00B | 0.00% |
| 2012-01-31 | $0.00B | $0.00B | 0.00% |
| 2011-10-31 | $0.00B | $0.00B | 0.00% |
| 2011-01-31 | $0.00B | $0.00B | 0.00% |
| 2010-10-31 | $0.00B | $0.00B | 0.00% |
| 2010-01-31 | $0.00B | $0.00B | 0.00% |
| 2009-10-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $182.674B | 22.10 |
| Intuitive Surgical (ISRG) | United States | $168.441B | 69.82 |
| IDEXX Laboratories (IDXX) | United States | $50.647B | 52.71 |
| Edwards Lifesciences (EW) | United States | $47.649B | 31.58 |
| Alcon (ALC) | Switzerland | $39.055B | 26.22 |
| DexCom (DXCM) | United States | $31.616B | 47.42 |
| IQVIA Holdings (IQV) | United States | $31.516B | 17.81 |
| Mettler-Toledo (MTD) | United States | $26.326B | 31.25 |
| STERIS (STE) | Ireland | $24.376B | 25.94 |
| Waters (WAT) | United States | $17.288B | 23.75 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.986B | 0.00 |
| Hologic (HOLX) | United States | $14.940B | 16.19 |
| Penumbra (PEN) | United States | $9.803B | 71.61 |
| Sysmex ADR (SSMXY) | Japan | $8.284B | 26.32 |
| Globus Medical (GMED) | United States | $8.171B | 18.85 |
| Masimo (MASI) | United States | $7.836B | 26.37 |
| Teleflex (TFX) | United States | $5.507B | 8.89 |
| Glaukos (GKOS) | United States | $5.149B | 0.00 |
| TransMedics (TMDX) | United States | $4.050B | 61.56 |
| Integer Holdings (ITGR) | United States | $3.743B | 18.68 |
| LivaNova (LIVN) | United Kingdom | $2.886B | 16.52 |
| Alphatec Holdings (ATEC) | United States | $2.357B | 0.00 |
| Veracyte (VCYT) | United States | $2.315B | 31.99 |
| PROCEPT BioRobotics (PRCT) | United States | $2.189B | 0.00 |
| Artivion (AORT) | United States | $2.036B | 102.71 |
| Nihon Kohden (NHNKY) | Japan | $1.858B | 22.18 |
| Elekta AB (EKTAY) | Sweden | $1.858B | 17.38 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.076B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.066B | 6.11 |
| IRadimed (IRMD) | United States | $0.897B | 43.54 |
| Tandem Diabetes Care (TNDM) | United States | $0.747B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.734B | 0.00 |
| AxoGen (AXGN) | United States | $0.729B | 0.00 |
| SiBone (SIBN) | United States | $0.675B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.518B | 9.15 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.459B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.446B | 3.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.369B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.368B | 9.36 |
| Delcath Systems (DCTH) | United States | $0.364B | 86.75 |
| RxSight (RXST) | United States | $0.357B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.291B | 0.00 |
| NeuroPace (NPCE) | United States | $0.285B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.283B | 19.54 |
| Alpha Tau Medical (DRTS) | Israel | $0.266B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.257B | 0.00 |
| Neuronetics (STIM) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.222B | 0.00 |
| 908 Devices (MASS) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
| Inogen (INGN) | United States | $0.204B | 0.00 |
| CVRx (CVRX) | United States | $0.198B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.162B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.114B | 0.00 |
| InspireMD (NSPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.096B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.071B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Vyome Holdings (HIND) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.36 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |